Dynavax Technologies
DVAX
#5487
Rank
$1.28 B
Marketcap
$10.96
Share price
0.05%
Change (1 day)
-14.93%
Change (1 year)

Dynavax Technologies (DVAX) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.41 Billion USD

According to Dynavax Technologies 's latest financial reports the company's total liabilities are $0.41 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dynavax Technologies - Total liabilities on balance sheet (from 2003 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.38 B3.85%
2023-12-31$0.37 B-7.36%
2022-12-31$0.40 B-50.44%
2021-12-31$0.81 B177.3%
2020-12-31$0.29 B8.79%
2019-12-31$0.27 B83.18%
2018-12-31$0.14 B668.45%
2017-12-31$19.23 M-6.07%
2016-12-31$20.47 M-30.71%
2015-12-31$29.55 M-21.83%
2014-12-31$37.8 M106.29%
2013-12-31$18.32 M-26.47%
2012-12-31$24.92 M-27.16%
2011-12-31$34.22 M6.48%
2010-12-31$32.13 M-27.11%
2009-12-31$44.09 M-40.79%
2008-12-31$74.46 M-8.42%
2007-12-31$81.31 M241.41%
2006-12-31$23.81 M315.67%
2005-12-31$5.73 M-58.39%
2004-12-31$13.77 M-84.49%
2003-12-31$88.78 M1.06%
2002-12-31$87.84 M77.35%
2001-12-31$49.53 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Agenus
AGEN
$0.51 B 24.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$11.00 B 2,567.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$77.63 B 18,727.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$37.07 B 8,891.24%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$68.48 B 16,507.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
$61.28 B 14,761.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$115.63 B 27,941.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.60 B 7,806.05%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
$80.52 B 19,426.73%๐Ÿ‡บ๐Ÿ‡ธ USA